The purpose of this grant is to support the investigation of clinical variation in care, and development of a continuous quality improvement strategy to address unwarranted variation or improve the quality of systems and care.
October 2022
Recipient
Project
Amount
What was approved
Approved for Illawarra Shoalhaven Local Health District
$80,000
$80,000 was approved by
Cancer Institute NSW’s Chief Executive Officer/Chief Cancer OfficerDate approved
October 2022Location of the recipient
Warrawong 2502About the grant
Applications approved
5
Applications received
6
Innovation in Cancer Control - Investigating Clinical Variation and Addressing Unwarranted Clinical Variation
Agency funding this grant
Cancer Institute NSWProgram term
15 monthsWhat was approved
Approved for Northen Sydney Local Health District
$80,000
$80,000 was approved by
Cancer Institute NSW’s Chief Executive Officer/Chief Cancer OfficerDate approved
October 2022Location of the recipient
St Leonards 2065About the grant
Applications approved
5
Applications received
6
Innovation in Cancer Control - Investigating Clinical Variation and Addressing Unwarranted Clinical Variation
Agency funding this grant
Cancer Institute NSWProgram term
15 monthsWhat was approved
Approved for South Western Sydney Local Health District
$80,000
$80,000 was approved by
Cancer Institute NSW’s Chief Executive Officer/Chief Cancer OfficerDate approved
October 2022Location of the recipient
Liverpool 2170About the grant
Applications approved
5
Applications received
6
Innovation in Cancer Control - Investigating Clinical Variation and Addressing Unwarranted Clinical Variation
Agency funding this grant
Cancer Institute NSWProgram term
27 monthsWhat was approved
Approved for St Vincent's Health Network
$80,000
$80,000 was approved by
Cancer Institute NSW’s Chief Executive Officer/Chief Cancer OfficerDate approved
October 2022Location of the recipient
Darlinghurst 2010About the grant
Applications approved
5
Applications received
6
Innovation in Cancer Control - Investigating Clinical Variation and Addressing Unwarranted Clinical Variation
Agency funding this grant
Cancer Institute NSWProgram term
27 monthsWhat was approved
Approved for Sydney Local Health District
$80,000
$80,000 was approved by
Cancer Institute NSW’s Chief Executive Officer/Chief Cancer OfficerDate approved
October 2022Location of the recipient
Forest Lodge 2037About the grant
Applications approved
5
Applications received
6
Innovation in Cancer Control - Investigating Clinical Variation and Addressing Unwarranted Clinical Variation
Agency funding this grant
Cancer Institute NSWProgram term
25 months